 novel vitamin analog growth human breast cancer vitro vivo hypercalcemia OH growth certain malign cell hypercalcem effect clinic applic novel vitamin analog OH oct capabl differenti prolifer hypercalcemia present studi oct treatment breast cancer estrogen receptor ER oct prolifer er-posit er-neg breast cancer cell vitro time- dose-depend manner cell number thymidin uptak antiprolif effect concentr low oct treatment cell oct day reduct cell number vehicle-tr cell oct order magnitud potent OH prolifer cell vivo effect oct athym mice er-neg tumor xenograft human breast carcinoma intratumor administr oct time week growth tumor time- dose-depend manner antitumor effect microgram/kg BW oct microgram/kg BW adriamycin rel tumor weight group day vehicle-tr group effect oct adriamycin addit rel tumor weight day combin treatment vehicle-tr group oral administr oct effect rel tumor weight oct-treat group BW mean sem vehicle-tr group intratumor oral administr oct serum calcium level anim result oct potent inhibitor prolifer breast cancer cell ER oct growth breast cancer vivo hypercalcemia oct new strategi treatment breast carcinoma regardless ER statu